Emergent has entered a strategic financial investment agreement with Swiss Rockets to support the latter’s biotech portfolio.

Q4 2024 Earnings Call Transcript March 11, 2025 Operator: Welcome to the SIGA Business Update Call. Before we turn the call ...

While public health authorities in Texas and elsewhere are doing their best to contain the latest outbreaks, RFK Jr. is going ...

NIH-sponsored trial data offers further evidence to help inform mpox treatment decisions.

Over the past couple of weeks, advertisements have been popping up on TV and social media, urging the closure of the Oregon National Primate Center.

For more than a decade, I have worked as a physician and public-health expert responding to infectious diseases around the ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...

A column by Winona LaDuke, an Ojibwe writer and economist on Minnesota’s White Earth Reservation. She also is co-curator of ...

In fact, although never before so brutally and blatantly, the United States has bribed and bullied the WHO from the earliest ...

The European Union has responded with retaliatory tariffs of its own, with a special focus on products from red states.

A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.

But history also reveals that the aftershocks of pandemics can linger for far longer than five years. Signs suggest our ...